4.6 Article

Efficacy of Functional Remediation in Bipolar Disorder: A Multicenter Randomized Controlled Study

期刊

AMERICAN JOURNAL OF PSYCHIATRY
卷 170, 期 8, 页码 852-859

出版社

AMER PSYCHIATRIC PUBLISHING, INC
DOI: 10.1176/appi.ajp.2012.12070971

关键词

-

资金

  1. ETS grant from the Spanish Ministry of Economy and Competitiveness [PI080180, PI08/90825, PI08/90327, PI08/90675, PI08/90224, PI08/90654, PI08/90189, PI08/90916, PI08/90416, PI08/90094]
  2. Carlos III Health Institute
  3. General Subdepartment for Evaluation and Research Promotion
  4. European Regional Fund
  5. European Union
  6. Una manera de hacer Europa
  7. CIBERSAM
  8. Commissioner for Universities and Research, Ministry of Innovation, Universities and Enterprise, Catalan Government [2009 SGR 1022]
  9. Almirall
  10. AstraZeneca
  11. Bristol-Myers Squibb
  12. Cephalon
  13. Eli Lilly
  14. GlaxoSmithKline
  15. Janssen-Cilag
  16. Lundbeck
  17. Merck
  18. Novartis
  19. Otsuka
  20. Pfizer
  21. Sanofi-Aventis
  22. Schering-Plough
  23. Spanish Ministry of Science and Innovation (CIBERSAM)
  24. FIS
  25. Health Ministry, IDIBELL Foundation
  26. Abbott
  27. AMGEN
  28. Caja Navarra
  29. Alicia Koplowitz Foundation
  30. Ministry of Science and Innovation
  31. Ministry of Health
  32. Ministry of Economy and Competitiveness
  33. Mutua Madrilena
  34. Roche
  35. Servier
  36. Takeda
  37. Cambridge University Press
  38. Solal Ed
  39. Ars Medica
  40. Giovani Fioriti Ed
  41. Medipage
  42. La Esfera de Los Libros
  43. Morales i Torres Ed
  44. Panamericana
  45. Mayo Ed.
  46. Columna
  47. Spanish Ministry of Economy and Competitiveness
  48. Alicia Koplowitz Grant for Short-Term Placements from the Alicia Koplowitz Foundation
  49. AGAUR
  50. Boehringer-Ingelheim
  51. Janssen
  52. Medtronic
  53. Rovi
  54. Spanish Ministry of Health
  55. Spanish Ministry of Science and Innovation
  56. Wyeth
  57. Alexza
  58. Ferrer
  59. Forest Research Institute
  60. Gedeon Richter
  61. Jazz
  62. Johnson Johnson
  63. Organon
  64. Pierre-Fabre
  65. Qualigen
  66. Shire
  67. Solvay
  68. Seventh European Framework Programme (ENBREC)
  69. Stanley Medical Research Institute
  70. United Biosource Corporation

向作者/读者索取更多资源

Objective: The authors sought to assess the efficacy of functional remediation, a novel intervention program, on functional improvement in a sample of euthymic patients with bipolar disorder. Method: In a multicenter, randomized, rater-blind clinical trial involving 239 outpatients with DSM-IV bipolar disorder, functional remediation (N=77) was compared with psychoeducation (N=82) and treatment as usual (N=80) over 21 weeks. Pharmacological treatment was kept stable in all three groups. The primary outcome measure was improvement in global psychosocial functioning, measured blindly as the mean change in score on the Functioning Assessment Short Test from baseline to endpoint. Results: At the end of the study, 183 patients completed the treatment phase. Repeated-measures analysis revealed significant functional improvement from baseline to endpoint over the 21 weeks of treatment (last observation carried forward), suggesting an interaction between treatment assignment and time. Tukey's post hoc tests revealed that functional remediation differed significantly from treatment as usual, but not from psychoeducation. Conclusions: Functional remediation, a novel group intervention, showed efficacy in improving the functional outcome of a sample of euthymic bipolar patients as compared with treatment as usual.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据